Head-to-head · Value Score
CoreAge Rx vs PreventiveMD
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, PreventiveMD a 78. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-namePreventiveMD
#92 · Grade B- · Fair Price
Est. first month
From $83/mo (as low as, term not published, all-in, compounded)
Save ~94% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 78 — an est. $99/mo first month, with no teaser step-up baked in. PreventiveMD isn't out of it: Shoppers who want compounded GLP-1s from $83/mo all-in with brand Wegovy and Zepbound upgrade paths.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | PreventiveMD |
|---|---|---|
| Value Score | 93 (A+) | 78 (B-) |
| Est. first month | $99/mo | From $83/mo (as low as, term not published, all-in, compounded) |
| Save vs brand-name | ~89% | ~94% |
| Semaglutide | $99/mo | From $83/mo (as low as, term not published, all-in, compounded) |
| Tirzepatide | $149/mo | From $97/mo (as low as, term not published, all-in, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 36 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
PreventiveMD
PreventiveMD is a physician-guided telehealth platform for GLP-1 weight loss and peptide therapy, offering compounded semaglutide from $83/mo all-in and compounded tirzepatide from $97/mo all-in.
Why it's a deal
- Compounded semaglutide from $83/mo and tirzepatide from $97/mo, billed as one all-in monthly price
- Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
- US-licensed provider reviews requests within 24 hours — no video visit required
- You aren't charged until a provider approves; checkout places an authorization hold only
- LegitScript-certified; works exclusively with state-licensed US 503A compounding pharmacies
The fine print
- Both figures are 'as low as' rates and the qualifying term is not published anywhere — the checkout is gated, so whether $97 is month-to-month or a multi-month prepay cannot be established before signing up
- Brand-name routes are priced separately and do carry a fee: $49/mo membership plus medication from $149/mo for Foundayo and Wegovy, from $299/mo for Zepbound
- No state count is published, and a state-variant waitlist implies some states are unserved
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to PreventiveMD.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.